Fred Robertson, CEO of TomoTherapy said, This is a major milestone for TomoTherapy and, in turn, for cancer centers of all sizes," said Fred Robertson, CEO of TomoTherapy. TomoDirect significantly improves the throughput of our system, and widens the TomoTherapy treatment options available for clinical use. Now, more cancer patients can benefit from true, next-generation treatment technology.